Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks

Virology Journal

Volumn 8, Issue , 2011, Pages

  Liu, Chun G ^a   Liu, Ming ^b   Liu, Fei ^a   Liu, Da F ^a   Zhang, Yun ^a   Pan, Wei Q ^a   Chen, Hao ^a   Wan, Chun H ^a   Sun, En C ^a   Li, Hong T ^a   Xiang, Wen H ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b GUIZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA VACCINE; IMMUNOLOGICAL ADJUVANT; MONTANIDE ISA 206; MONTANIDE ISA 70M; UNCLASSIFIED DRUG; INFLUENZA VACCINE; OIL; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CHICKEN; CONTROLLED STUDY; DRUG EFFECT; DUCK; IMMUNIZATION; INFECTION PREVENTION; NONHUMAN; PROCESS OPTIMIZATION; ANIMAL; BLOOD; CLOACA; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; ISOLATION AND PURIFICATION; MORTALITY; PATHOLOGY; PHARYNX; SURVIVAL; VIROLOGY;

ANAS; AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; CLOACA; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; OILS; PHARYNX; SURVIVAL ANALYSIS;

EID: 79959468798     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-321     Document Type: Article

References (20)

1. Evolution and ecology of influenza A virus. RG Webster WJ Bean OT Gorman TM Chambers Y Kawaoka, Microbiol Rev 1992 56 152 79 1579108
2. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. KS Li Y Guan J Wang GJ Smith KM Xu L Duan,, et al. Nature 2004 430 209 13 10.1038/nature02746 15241415 (Pubitemid 38902429)
3. Probable person-to-person transmission of avian influenza A (H5N1). K Ungchusak P Auewarakul SF Dowell R Kitphati W Auwanit P Puthavathana,, et al. N Engl J Med 2005 352 333 40 10.1056/NEJMoa044021 15668219
4. Future influenza vaccines and the use of genetic recombinants. D Kilbourne, Bull World Health Organ 1969 41 643 5 5309489
5. Influenza vaccines generated by reverse genetics. K Subbarao JM Katz, Curr Top Microbiol Immunol 2004 283 313 42 15298174 (Pubitemid 38667564)
6. Generation High Yield Vaccine Strain Wholly Derived from Avian Influenza Viruses by Reverse Genetics. M Liu Y Zhang CG Liu WQ Pan CN Liu T Yang, Chinese Journal of Biotechnology 2006 22 720 6 10.1016/S1872-2075(06)60053-8 17037192
7. The influenza virus gene pool in a poultry market in South central China. M Liu S He D Walker N Zhou DR Perez B Mo,, et al. Virology 2003 305 267 75 10.1006/viro.2002.1762 12573572 (Pubitemid 36259661)
8. The NA Gene of N3 Avian influenza virus Expressed in Insect Cells. M Liu CG Liu Y Zhang T Yang, Progress in Veterinary Medicine 2005 26 50 4
9. Veterinary vaccine adjuvants. http://www.seppic.com/animal-health/ vaccine-adjuvant-@93/view-1111-category.html
10. Adjuvants and Antibody Production: Dispelling the Myths Associated with Freund's Complete and Other Adjuvants. F Harold J Stills, ILAR Journal 2005 46 280 93 15953835 (Pubitemid 40872935)
11. An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits. BA Johnston H Eisen D Fry, Lab Anim Sci 1991 41 15 21 1849580
12. Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits. PP Leenaars CF Hendriksen AF Angulo MA Koedam E Claassen, Vet Immunol Immunopath 1994 40 225 241 10.1016/0165-2427(94)90022-1 (Pubitemid 24066510)
13. Comparison of adjuvants for immune potentiating properties and side effects in mice. PP Leenaars CF Hendriksen MA Koedam I Claassen E Claassen, Vet Immunol Immunopath 1995 48 123 38 10.1016/0165-2427(94)05413-M
14. Assessment of side effects induced by injection of different adjuvant/antigen combinations in rabbits and mice. PP Leenaars MA Koedam PW Wester V Baumans E Claassen CF Hendriksen, Lab Anim 1998 32 387 406 10.1258/002367798780599884 9807752 (Pubitemid 28482473)
15. An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea. JG Choi YJ Lee YJ Kim EK Lee OM Jeong HW Sung,, et al. J Vet Sci 2008 9 67 74 10.4142/jvs.2008.9.1.67 18296890
16. Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. CM James YY Foong JP Mansfield SG Fenwick TM Ellis, Vaccine 2007 25 5892 901 10.1016/j.vaccine.2007.05.023 17583393 (Pubitemid 47043219)
17. Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. CM James YY Foong JP Mansfield AR Vind SG Fenwick TM Ellis, Vaccine 2008 26 5345 51 10.1016/j.vaccine.2008.08.008 18723069
18. Influence of adjuvant formulation on induced host protection in a mouse vaccination model against Trichinella spiralis. S Deville AD Pooter V Lainé-Prade M Cote S Ascarateil J Aucouturier,, et al. XIth International Conference on Trichinellosis, California: Manchester Conference Center University of San Diego San Diego, Douglas F, 2004 48
19. Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection. SI Jang HS Lillehoj SH Lee KW Lee MS Park GR Bauchan,, et al. Vet Parasitol 2010 172 221 8 10.1016/j.vetpar.2010.04.042 20541870
20. Comparison of adjuvant for porcine circovirus type 2 inactivated vaccines. CM Liu YW Wei CF Zhang ZX Zhang J Yuang, Chinese Journal of Preventive Veterinary Medicine 2007 29 690 3